Pharmagreen Biotech Inc.
PHBI OTC
SEC CIK 1435181
Follow Pharmagreen Biotech
Weekly email: filings, results
Net income
−$875.5K
+80.7% vs prior year
EPS, diluted
-
Operating cash flow
−$426.6K
−107% vs prior year
Operating income
−$1.1M
−48% vs prior year
Source: SEC XBRL filings · latest filing
Show the numbers
| Year | Net income |
|---|---|
| FY22 | −$875.5K |
| FY21 | −$4.5M |
| FY20 | −$2.5M |
| FY19 | −$767.5K |
| FY18 | −$1.1M |
| FY17 | - |